OBJECTIVE: To study the sleep characteristics, pulmonary function, and their relationships in an enzyme naive population of patients with mucopolysaccharidoses (MPS) II (Hunter syndrome). STUDY DESIGN: The analyzed subjects (30 patients with MPS II with a median age of 9 years) had been enrolled in an MPS II natural history study and a phase I/II enzyme replacement clinical study in which they underwent standard polysomnography including spirometry and plethysmography, if cooperative. Descriptive statistics and nonparametric correlation were performed for demographic, sleep, and pulmonary function variables. RESULTS: Median apnea-hypopnea index was 6.4, with obstructive sleep apnea observed in 27/30 subjects. Sleep architecture was characterized by diminished rapid-eye movement sleep duration (median 13%), and decline in sleep efficiency and slow-wave sleep duration in older individuals. Oxygen desaturation below 90% occurred in 26/30 subjects, and hypoventilation above 50 Torr occurred in 11/23 subjects with accurate end-tidal carbon dioxide recordings. Of 15 subjects with reliable spirometry, median forced expiratory volume in 1 second was below 80% predicted in 12/15 subjects. Forced expiratory volume in 1 second in percent-predicted was inversely related to apnea-hypopnea index and increase from baseline end-tidal carbon dioxide (P=.023, rs=-0.58), (P<.001, rs=-0.82). CONCLUSION: Sleep in MPS II is characterized by obstructive sleep apnea, altered sleep architecture, and impaired gas exchange. Sleep disruption is related to daytime pulmonary function, thus both systems should be evaluated when sleep abnormalities are suspected.
OBJECTIVE: To study the sleep characteristics, pulmonary function, and their relationships in an enzyme naive population of patients with mucopolysaccharidoses (MPS) II (Hunter syndrome). STUDY DESIGN: The analyzed subjects (30 patients with MPS II with a median age of 9 years) had been enrolled in an MPS II natural history study and a phase I/II enzyme replacement clinical study in which they underwent standard polysomnography including spirometry and plethysmography, if cooperative. Descriptive statistics and nonparametric correlation were performed for demographic, sleep, and pulmonary function variables. RESULTS: Median apnea-hypopnea index was 6.4, with obstructive sleep apnea observed in 27/30 subjects. Sleep architecture was characterized by diminished rapid-eye movement sleep duration (median 13%), and decline in sleep efficiency and slow-wave sleep duration in older individuals. Oxygen desaturation below 90% occurred in 26/30 subjects, and hypoventilation above 50 Torr occurred in 11/23 subjects with accurate end-tidal carbon dioxide recordings. Of 15 subjects with reliable spirometry, median forced expiratory volume in 1 second was below 80% predicted in 12/15 subjects. Forced expiratory volume in 1 second in percent-predicted was inversely related to apnea-hypopnea index and increase from baseline end-tidal carbon dioxide (P=.023, rs=-0.58), (P<.001, rs=-0.82). CONCLUSION: Sleep in MPS II is characterized by obstructive sleep apnea, altered sleep architecture, and impaired gas exchange. Sleep disruption is related to daytime pulmonary function, thus both systems should be evaluated when sleep abnormalities are suspected.
Authors: Angela John; Simone Fagondes; Ida Schwartz; Ana Cecília Azevedo; Patrícia Barrios; Paulo Dalcin; Sérgio Menna-Barreto; Roberto Giugliani Journal: Am J Med Genet A Date: 2011-06-02 Impact factor: 2.802
Authors: Ana Maria Martins; Ana Paula Dualibi; Denise Norato; Edna Tiemi Takata; Emerson S Santos; Eugênia Ribeiro Valadares; Gilda Porta; Gisele de Luca; Gustavo Moreira; Helena Pimentel; Janice Coelho; Jaime Moritz Brum; José Semionato Filho; Marcelo Soares Kerstenetzky; Márcia R Guimarães; Maria Verónica Muñoz Rojas; Paulo Cesar Aranda; Ricardo Flores Pires; Rodrigo G C Faria; Ronald Moura Vale Mota; Ursula Matte; Zelita Caldeira Ferreira Guedes Journal: J Pediatr Date: 2009-10 Impact factor: 4.406
Authors: Merrill S Wise; Cynthia D Nichols; Madeleine M Grigg-Damberger; Carole L Marcus; Manisha B Witmans; Valerie G Kirk; Lynn A D'Andrea; Timothy F Hoban Journal: Sleep Date: 2011-03-01 Impact factor: 5.849
Authors: Mark J Kohler; Swetlana Thormaehlen; J Declan Kennedy; Yvonne Pamula; Cameron J van den Heuvel; Kurt Lushington; A James Martin Journal: J Clin Sleep Med Date: 2009-12-15 Impact factor: 4.062
Authors: Joseph Muenzer; Olaf Bodamer; Barbara Burton; Lorne Clarke; Gudrun Schulze Frenking; Roberto Giugliani; Simon Jones; Maria Verónica Muñoz Rojas; Maurizio Scarpa; Michael Beck; Paul Harmatz Journal: Eur J Pediatr Date: 2011-10-29 Impact factor: 3.183
Authors: William I Wooten; Marianne S Muhlebach; Joseph Muenzer; Ceila E Loughlin; Bradley V Vaughn Journal: J Clin Sleep Med Date: 2016-12-15 Impact factor: 4.062
Authors: Gustavo A Moreira; Sandra O Kyosen; Camilla L Patti; Ana Maria Martins; Sergio Tufik Journal: Sleep Breath Date: 2014-04-05 Impact factor: 2.816
Authors: Luis González-Gutiérrez-Solana; Encarnación Guillén-Navarro; Mireia Del Toro; Jaime Dalmau; Antonio González-Meneses; María L Couce Journal: Medicine (Baltimore) Date: 2018-07 Impact factor: 1.889
Authors: M Rutten; P Ciet; R van den Biggelaar; E Oussoren; J G Langendonk; A T van der Ploeg; M Langeveld Journal: Orphanet J Rare Dis Date: 2016-04-26 Impact factor: 4.123